Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA vs EACA in Pediatric Congenital Heart Surgery
NCT02656472Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hemorrhage, Systemic Inflammatory Response Syndrome (SIRS), sponsored by Wake Forest University Health Sciences. Started Feb 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhageSystemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02656472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656472.